Idiomas      
   

Página Inicial
principais dúvidas
epidemiologia
patogeniese
diagnóstico
tratamento
prevenção
conheça mais sobre os autores
conheça mais sobre os autores
conheça mais sobre os autores
Download de artigos relacionados

Autores do site

AUTORES DO SITE - Jorge Casseb

Endereço Comercial:
Av. Dr. Arnaldo 455, Sala 2345
Tel 3066 7193
Fax: 3081 7190
Email:
j31@hotmail.com
jorge@htlv.com.br
Consultório:


FORMAÇÃO ACADÊMICA


Graduação: Medicina; Faculdade de Medicina da Pará - Brasil (1984-1989). Fundação Educacional do Estado do Pará.


Residência Médica : Doenças Infecciosas e Parasitárias, Instituto de Infectologia "Emílio Ribas", São Paulo -Brasil (1990-1991).


Mestrado em Alergia e Imunopatologia - Divisão de Imunologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo- Brasil (1992-1995).

Research Fellow em Saúde Pública e Virologia - School of Public Health, University of Califórnia at Berkeley, e Viral and Rickettsial Disease Laboratory, California Department of Health Services, Berkeley, California, EUA, April de 1995 ate Maio 1997. NIH Fogarty International AIDS Training Grant (D43#00003).

Doutorado em Medicina na Disciplina de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo- Brasil (1997-1999).

TRABALHOS PUBLICADOS

1) Nakauchi CM; Linhares AC; Maruyama K; Kansaki LI; Macedo JE; Azevedo VN; Casseb JS. Prevalence of human T cell leukemia virus-I (HTLV-I) antibody among populations living in the Amazon region of Brazil (preliminary report). Memorias do Instituto Oswaldo Cruz 85: 29-33. 1990.

2) Casseb JS; Caterino-de-Araujo. Difficulties in diagnosing atypical primary HIV-1 infection: report of a case. Revista do Instituto de Medicina Tropical de São Paulo, May-jun, 36: 287-92, 1994.

3) de Araujo AC; Casseb JS; Neitzert E; De Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in São Paulo, Brazil. European Journal of Epidemiology 10: 165-71, 1994.

4) Casseb JS; Benard G; Saito R; Brígido LFM; Tanaami; D; Joaquim ES; Duarte AJS. Value of PHA Lymphocyte Proliferation Test in the Immune Evaluation of HIV-infected Patients in Brazil. Journal of Invest Allergo Clin Immunology 5 (6): 347-9, 1995.

5) Hendry RM; Hanson CV; Bongertz V; Morgado M; Duarte A; Casseb J; Brígido L; Sabino E; Diaz R; Galvao-Castro B. Immunoreactivity of Brazilian HIV Isolates with Different V3 motifs. Memorias do Instituto Oswaldo Cruz 91:347-8, 1996.

6) Nicolau JE; Benard G; Fonseca LAM; Casseb JSR; Tanji MM: Cianga-Tanji M; Linassi PR; Sato MN; Lorenzi T; A.J.S. Duarte. HIV Heterosexual Transmission to Stable Sexual Partners of HIV-Infected Brazilian Hemophiliacs. São Paulo Medical Journal 114:1186-89, 1996.

7) Kansaki LI; Maruyama K; Fukushima T; Tamez-Guerra RS; Trejo-Avila LM; Casseb JSR; Neitzert E; Macedo JE. Markers of human T lymphotropic virus type I in patients with cancer of uterine cervix in Amazon, Brazil. International Journal of Oncology 10:1021-1024, 1997.

8) Casseb J, Hong MA, Salomao S, Duarte AJS, Gallo D, and Hendry RM. Coinfection with Human Immunodeficiency Virus and Human T-Cell Lymphotropic Virus Type I: Reciprocal activation with clinical and immunological consequences. Clinical Infectious Diseases, 25: 1259-1260, 1997.

9) Casseb J; Souza T; Pierre-Lima MT; Yeh E, Hendry RM; Gallo D. Testing problems in diagnosing HTLV infection among injection drug users (IDU) with AIDS in São Paulo City, Brazil. AIDS Research Human Retroviruses, 13:1639-1641, 1997.

10) Casseb J; Salomão S; Hong MA; Caterino-de-Araujo A; Duarte AJS. Prevalence of HTLV-I and HTLV-II antibodies among HIV-1-asymptomatic patients in São Paulo, Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 39: 213-215, 1997.

11) Gonsalez C, Casseb J, Monteiro FGV, Paula-Neto JB, Fernandez RB, Silva MV, Camargo ED, Mairinque JMP, Tavares LC. Use of doxycycline for leptospirosis after high-risk exposure in São Paulo, Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 40: 59-61, 1998.

12) Duarte AJS, Hong MA, Camargo LS, Nunes DF, Carvalho A, Sato MN, Benard G, Brigido LFM, Casseb J. Cytokine profile and natural killer activity among Brazilian HIV-1-infected subjects. Memorias do Instituto Oswaldo Cruz 93: 403-404, 1998.

13) Caterino-de-Araujo A, Santos-Fortuna E, Rossini MAAA, Santos IMR, Casseb J, Hendry MR. HIV-1 subtype B and F circulating in children from São Paulo, Brazil. In Epidemiology and prevention section, XII World AIDS Conference 109-112, 1998.

14) Casseb J, Oliveira JR F. A possible case of human T-cell lymphotropic virus type I (HTLV-I) transmission through sexual assault. Sexually Transmitted Diseases, 25: 327-328, 1998.

15) Casseb J, Hong MA, Gonsalez C, Brígido LF, Duarte AJS, Hendry RM. Two variants of HIV-1 B serotype are transmitted heterosexually in São Paulo, Brazil. Brazilian Journal of Biomedical Research, 31: 1246-1247, 1998.

16) Casseb J. Is HTLV-I more clever than HIV-1? Clinical Infectious Diseases, 27: 1309-1310, 1998.

17) Hong MA, Wakim VL, Salomão S, Camargo LS, Casseb J, Duarte AJS. IL-2 and IFN-g, but not IL-4 secretion by peripheral blood mononuclear cells (PBMC) are related to CD4+ T cells and clinical status in Brazilian HIV-1-infected subjects. Revista do Instituto de Medicina Tropical de São Paulo, , 40: 351-354, 1998.

18) Casseb J, Pereira Junior LC, Silva GL, Medeiros LA. Decreasing mortality and morbidity in adult AIDS patients from 1995 to 1997 at the Institute of Infectious Diseases "Emílio Ribas" (IIER), São Paulo, Brazil.- AIDS Patient Care and STDs 13:213-214, 1999.

19) Caterino-de-Araujo A, Santos-Fortuna E, Rossini MAAS, Ramos-dos-Santos IM, Casseb J, Hendry RM. HIV-1 subtypes B and F circulating in children from São Paulo, Brazil. Journal of Tropical Pediatrics, 45: 265-270, 1999.

20) Casseb J. Is HTLV-I more clever than HIV-1- Reply letter? Clinical Infectious Diseases, 28: 1356, 1999.

21) Fonseca LA, Reingold AL, Casseb J, Brígido LFM, Duarte AJS. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV asymptomatic patients in São Paulo, Brazil. International Journal of Epidemiology, 28:1156-1160, 1999.

22) Veiga APR, Casseb J, Duarte AJS. Reconstrução da resposta imune em pacientes infectados pelo HIV-1 em terapia anti-retroviral combinada. Estudos Avançados USP, 13:165-166, 1999.

23) Araujo FO, Casseb J, Duarte AJS. Receptores celulares e resistência para infecção pelo HIV-1. Estudos Avançados USP, 13:181-182, 1999.

24) Casseb J. Possible mechanism for positive interaction of HTLV-I on liver disease in an HCV-infected Japanese cohort. Journal of Infectious Diseases, 181: 379, 2000.

25) Casseb J & Penalva-de-Oliveira AC. The of tropical spastic paraparesis/Human T cell leukemia type 1-associated myelopathy (TSP/HAM). Brazilian Journal of Medical and Biological Research, 33: 1395-1401, 2000.

26) Casseb J. Viral diversity in some immunodominant epitopes: Possible implications for retroviral immunopathogenesis. Journal of Infectious Diseases, 183: prelo, 2001

27) Casseb J, Orrico GS, Feijo RDP, Guaracy L, Medeiros LA. Lack of prior antiretroviral therapy is strongly associated with death among hospitalized adults with AIDS at the Institute of Infectious Diseases "Emílio Ribas", Sao Paulo, Brazil. AIDS Patient Care and STDs, prelo, 2001.

1.3. CAPITULO DE LIVRO:

1) Penalva-de-Oliveira AC, Annes M, Casseb J. IN: RETROVIROSES HUMANAS - HIV/AIDS: ALTERAÇÕES NEUROLOGÓCICAS: VERONESI R. FOCACCIA R.; LOMAR AV. ED. ATHENEU, RIO DE JANEIRO, BRASIL, 1999.

Produzido por Exfera Produtora web e Multimidia